HomeCNTX • NASDAQ
add
Context Therapeutics Inc
Previous close
$2.62
Day range
$2.59 - $2.73
Year range
$0.49 - $3.62
Market cap
243.48M USD
Avg Volume
886.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.80M | 220.26% |
Net income | -13.03M | -289.65% |
Net profit margin | — | — |
Earnings per share | -0.14 | — |
EBITDA | -13.80M | -220.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 66.00M | -30.11% |
Total assets | 68.49M | -30.20% |
Total liabilities | 8.02M | 180.37% |
Total equity | 60.47M | — |
Shares outstanding | 91.88M | — |
Price to book | 3.97 | — |
Return on assets | -46.72% | — |
Return on capital | -51.55% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -13.03M | -289.65% |
Cash from operations | -8.94M | -82.26% |
Cash from investing | -2.00M | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -10.94M | -213.65% |
Free cash flow | -8.55M | -101.40% |
About
Founded
2015
Headquarters
Website
Employees
15
